Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 616,796 |
|
|||||
| News | - | ||||||
| Day High | 4.37 | Low High |
|||||
| Day Low | 4.005 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sutro Biopharma Inc | STRO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.18 | -4.23% | 4.08 | 16:00:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.30 | 4.005 | 4.37 | 4.09 | 4.26 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,205 | 616,796 | $ 4.10 | $ 2,529,625 | - | 2.005 - 6.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:05:15 | 1 | $ 4.12 | USD |
Sutro Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 246.86M | 60.95M | - | 153.73M | -106.79M | -1.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sutro Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STRO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.00 | 5.0895 | 3.93 | 4.52 | 1,626,459 | 0.08 | 2.00% |
| 1 Month | 3.40 | 5.0895 | 3.30 | 4.21 | 870,216 | 0.68 | 20.00% |
| 3 Months | 5.20 | 6.13 | 3.20 | 4.42 | 1,074,714 | -1.12 | -21.54% |
| 6 Months | 2.55 | 6.13 | 2.13 | 4.23 | 950,791 | 1.53 | 60.00% |
| 1 Year | 5.28 | 6.13 | 2.005 | 4.12 | 729,115 | -1.20 | -22.73% |
| 3 Years | 18.37 | 23.70 | 2.005 | 6.81 | 571,024 | -14.29 | -77.79% |
| 5 Years | 10.50 | 28.30 | 2.005 | 9.15 | 436,482 | -6.42 | -61.14% |
Sutro Biopharma Description
| Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. |
